We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
+3.2%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$5.27B
AUM Growth
-$97.1M
(-1.8%)
Cap. Flow
-$25.4M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
214
New
21
Increased
77
Reduced
92
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$50.9M |
| 2 |
ThredUp
TDUP
|
+$42.1M |
| 3 |
Riskified
RSKD
|
+$31.6M |
| 4 |
Magnite
MGNI
|
+$20.8M |
| 5 |
Green Brick Partners
GRBK
|
+$20.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSOD
Cornerstone OnDemand, Inc.
CSOD
|
+$54M |
| 2 |
TWOU
2U Inc
TWOU
|
+$42.4M |
| 3 |
LivePerson
LPSN
|
+$28.3M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$22.8M |
| 5 |
BFX
BowFlex Inc.
BFX
|
+$21.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.43% |
| 2 | Healthcare | 17.99% |
| 3 | Industrials | 16.43% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
MacroGenics
MGNX
$259M
| $4.84M | 0.09% |
231,058
-28,384
| -11% | -$684K |
|
152
Silicon Laboratories
SLAB
$7.2B
| $4.75M | 0.09% |
33,862
+1,725
| +5% | +$259K |
|
153
SkinHealth Systems
SKIN
$83.3M
| $4.67M | 0.09% |
180,011
-31,506
| -15% | -$693K |
|
154
Biomerica
BMRA
$5.04M
| $4.64M | 0.09% |
128,920
+381
| +0.3% | +$12.5K |
|
|
EGIO
155
DELISTED
Edgio, Inc. Common Stock
EGIO
| $4.63M | 0.09% |
48,613
+2,129
| +5% | +$224K |
|
156
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $4.62M | 0.09% |
+405,834
| New | +$5.29M |
|
157
Monolithic Power Systems
MPWR
$67.9B
| $4.53M | 0.09% |
9,343
-1,843
| -16% | -$838K |
|
|
OLK
158
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $4.51M | 0.09% |
+185,830
| New | +$5.84M |
|
159
Fate Therapeutics
FATE
$322M
| $4.42M | 0.08% |
+74,492
| New | +$5.84M |
|
|
RDUS
160
DELISTED
Radius Health, Inc.
RDUS
| $4.4M | 0.08% |
354,888
+56,628
| +19% | +$816K |
|
|
CTG
161
DELISTED
Computer Task Group, Inc.
CTG
| $4.31M | 0.08% |
539,873
+15,260
| +3% | +$134K |
|
|
NEWR
162
DELISTED
New Relic, Inc.
NEWR
| $4.2M | 0.08% |
58,472
| – | – |
|
163
Xencor
XNCR
$1.6B
| $4.17M | 0.08% |
127,734
-23,810
| -16% | -$782K |
|
|
PRTK
164
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.99M | 0.08% |
821,654
-12,606
| -2% | -$69.5K |
|
|
SWIR
165
DELISTED
Sierra Wireless
SWIR
| $3.96M | 0.08% |
255,176
+211,693
| +487% | +$3.65M |
|
|
IMGN
166
DELISTED
Immunogen Inc
IMGN
| $3.84M | 0.07% |
+677,618
| New | +$3.92M |
|
167
Arcus Biosciences
RCUS
$3.66B
| $3.66M | 0.07% |
+104,848
| New | +$3.26M |
|
|
RVNC
168
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.57M | 0.07% |
+128,239
| New | +$3.66M |
|
|
ESPR
169
DELISTED
Esperion Therapeutics
ESPR
| $3.54M | 0.07% |
293,766
-39,319
| -12% | -$572K |
|
170
Arcturus Therapeutics
ARCT
$200M
| $3.5M | 0.07% |
+73,177
| New | +$3.28M |
|
171
Caribou Biosciences
CRBU
$165M
| $3.39M | 0.06% |
+141,951
| New | +$3.47M |
|
172
Mesa Laboratories
MLAB
$569M
| $3.23M | 0.06% |
+10,672
| New | +$3.03M |
|
173
Prothena Corp
PRTA
$468M
| $3.23M | 0.06% |
+45,304
| New | +$2.81M |
|
|
SGMO
174
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.14M | 0.06% |
348,473
+117,129
| +51% | +$1.16M |
|
175
Protolabs
PRLB
$2.14B
| $3.1M | 0.06% |
46,611
+12,045
| +35% | +$941K |
|
Similar funds
BC
AG
TA
ACP
TP
NSUP
ACG
CL
Granahan Investment Management's Q3 2021 Portfolio in Review
As of Q3 2021, Granahan Investment Management held 214 positions worth $5.27B, down 1.8% from $5.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Granahan Investment Management's Q3 2021 filing shows 21 new, 77 increased, 92 reduced and 21 closed positions. Its largest new stake was Riskified: 1,127,069 shares worth $25.7M. The largest sale was Cornerstone OnDemand, Inc., an estimated $54M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Industrials.
- Granahan Investment Management's largest Q3 2021 buy was Riskified: 1,127,069 shares worth $25.7M.
- Granahan Investment Management added most to Array Technologies in Q3 2021, an estimated $50.9M increase.
- Granahan Investment Management's biggest Q3 2021 reduction was 2U Inc, cutting an estimated $42.4M.
- Granahan Investment Management fully exited Cornerstone OnDemand, Inc. in Q3 2021, selling an estimated $54M.
- Granahan Investment Management's ten largest holdings make up 35% of its $5.27B portfolio in Q3 2021.
- Granahan Investment Management opened 21 new positions and closed 21 in Q3 2021.
- Granahan Investment Management's portfolio value fell 1.8% quarter-over-quarter to $5.27B.
Based on Granahan Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.